| Schedule of inventory, current |
At March 31, 2026 and December 31, 2025, the Company's net inventories consisted of the following: | | | | | | | | | | | | | | | | | March 31, 2026 | | December 31, 2025 | | | | | | | Raw materials and work in process | | $ | 10,061,130 | | | $ | 9,832,293 | | | | | | | | Finished goods | | 5,268,211 | | | 5,646,315 | | | Total inventories | | 15,329,341 | | | 15,478,608 | | | Less non-current inventories | | (9,875,505) | | | (9,253,090) | | | Total inventories classified as current | | $ | 5,453,836 | | | $ | 6,225,518 | |
|
| Schedule of inventory, noncurrent |
At March 31, 2026 and December 31, 2025, the Company's non-current inventories consisted of the following: | | | | | | | | | | | | | March 31, 2026 | | December 31, 2025 | | | | | | Vibativ raw materials | $ | 5,557,928 | | | $ | 4,883,895 | | | Kristalose raw materials | 2,263,417 | | | 2,261,500 | | | Vaprisol raw materials | 1,171,603 | | | 1,171,603 | | | Sancuso raw materials | 615,873 | | | 656,667 | | | | | | | Acetadote raw materials | 23,137 | | | 24,152 | | | Ifetroban raw materials | 40,878 | | | 40,879 | | | Kristalose finished Ggoods | 107,527 | | | 85,204 | | | Vibativ finished goods | — | | | 16,429 | | | Caldolor finished goods | 95,142 | | | 112,761 | | | | | | | | | | | Total inventories classified as non-current | $ | 9,875,505 | | | $ | 9,253,090 | |
|